Galectins as modulators of tumour progression
暂无分享,去创建一个
[1] A. Karlsson,et al. Galectins as inflammatory mediators , 2004, Glycoconjugate Journal.
[2] J. Trapani. Tumor-mediated apoptosis of cancer-specific T lymphocytes--reversing the "kiss of death"? , 2002, Cancer cell.
[3] John L. Wang,et al. Intracellular functions of galectins. , 2002, Biochimica et biophysica acta.
[4] L. Baum,et al. Presentation of Galectin-1 by Extracellular Matrix Triggers T Cell Death* , 2004, Journal of Biological Chemistry.
[5] J. Ochieng,et al. Extracellular functions of galectin-3 , 2004, Glycoconjugate Journal.
[6] N. Tinari,et al. Galectin‐3 overexpression protects from cell damage and death by influencing mitochondrial homeostasis , 2000, FEBS letters.
[7] R. Lotan,et al. Inhibition of N-(4-hydroxyphenyl)retinamide-Induced Apoptosis in Breast Cancer Cells by Galectin-3 , 2004, Cancer biology & therapy.
[8] M. Hirashima,et al. Human Ecalectin, a Variant of Human Galectin-9, Is a Novel Eosinophil Chemoattractant Produced by T Lymphocytes* , 1998, The Journal of Biological Chemistry.
[9] J. Folkman. Role of angiogenesis in tumor growth and metastasis. , 2002, Seminars in oncology.
[10] S. Kaufman,et al. Selective modulation of the interaction of alpha 7 beta 1 integrin with fibronectin and laminin by L-14 lectin during skeletal muscle differentiation. , 1994, Journal of cell science.
[11] Kevin C. Haudek,et al. Nucleocytoplasmic lectins. , 2004, Biochimica et biophysica acta.
[12] Tak W. Mak,et al. Pathways of apoptotic and non-apoptotic death in tumour cells , 2004, Nature Reviews Cancer.
[13] R. Hughes. Secretion of the galectin family of mammalian carbohydrate-binding proteins. , 1999, Biochimica et biophysica acta.
[14] G. Rabinovich,et al. Recombinant Galectin-1 and Its Genetic Delivery Suppress Collagen-Induced Arthritis via T Cell Apoptosis , 1999, The Journal of experimental medicine.
[15] Stefano Iacobelli,et al. Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response? , 2002, Trends in immunology.
[16] Michael J. Davis,et al. Shuttling of galectin-3 between the nucleus and cytoplasm. , 2002, Glycobiology.
[17] T. Yoshii,et al. CD29 and CD7 mediate galectin-3-induced type II T-cell apoptosis. , 2003, Cancer research.
[18] J. Ochieng,et al. Modulation of the biological functions of galectin-3 by matrix metalloproteinases. , 1998, Biochimica et biophysica acta.
[19] J. L. Wang,et al. Evidence for a role for galectin-1 in pre-mRNA splicing , 1997, Molecular and cellular biology.
[20] G. Jarvis,et al. Truncated galectin-3 inhibits tumor growth and metastasis in orthotopic nude mouse model of human breast cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[21] S. Deutscher,et al. Peptides specific to the galectin-3 carbohydrate recognition domain inhibit metastasis-associated cancer cell adhesion. , 2004, Carcinogenesis.
[22] J. Rini,et al. New animal lectin structures. , 1999, Current opinion in structural biology.
[23] F. Poirier. Roles of galectins in vivo. , 2002, Biochemical Society symposium.
[24] Yusuke Nakamura,et al. Functional variation in LGALS2 confers risk of myocardial infarction and regulates lymphotoxin-α secretion in vitro , 2004, Nature.
[25] S. Sidhu,et al. Phylogenetic analysis of the vertebrate galectin family. , 2004, Molecular biology and evolution.
[26] J. Ochieng,et al. Regulation of cellular adhesion to extracellular matrix proteins by galectin-3. , 1998, Biochemical and biophysical research communications.
[27] Y. Kloog,et al. Galectin-1 Augments Ras Activation and Diverts Ras Signals to Raf-1 at the Expense of Phosphoinositide 3-Kinase* , 2002, The Journal of Biological Chemistry.
[28] R. Hughes,et al. Effects of the carbohydrate‐binding protein galectin‐3 on the invasiveness of human breast carcinoma cells , 1996, Journal of cellular physiology.
[29] A. Hoeflich,et al. Comprehensive galectin fingerprinting in a panel of 61 human tumor cell lines by RT-PCR and its implications for diagnostic and therapeutic procedures , 2001, Journal of Cancer Research and Clinical Oncology.
[30] L. Yu,et al. This information is current as Macrophages Chemoattractant for Monocytes and Human Galectin-3 Is a Novel , 2000 .
[31] G. Rabinovich,et al. The antimetastatic effect of a single low dose of cyclophosphamide involves modulation of galectin-1 and Bcl-2 expression , 2001, Cancer Immunology, Immunotherapy.
[32] J. Hirabayashi,et al. Involvement of CD2 and CD3 in galectin-1 induced signaling in human Jurkat T-cells. , 2000, Glycobiology.
[33] R. Hughes. Galectins as modulators of cell adhesion. , 2001, Biochimie.
[34] 加塩 裕美子. Galectin-9 induces apoptosis through calcium-calpain-caspase-1 pathway , 2003 .
[35] H. Inohara,et al. Bh1 (nwgr) Domain of Bcl-2 Family Galectin-3: a Novel Antiapoptotic Molecule with a Functional Updated Version Citing Articles E-mail Alerts Galectin-3: a Novel Antiapoptotic Molecule with a Functional Bh1 (nwgr) Domain of Bcl-2 Family' , 2022 .
[36] J. Pollard. Tumour-educated macrophages promote tumour progression and metastasis , 2004, Nature Reviews Cancer.
[37] David A. Cheresh,et al. Role of integrins in cell invasion and migration , 2002, Nature Reviews Cancer.
[38] M. Huflejt,et al. Galectin-4 in normal tissues and cancer , 2003, Glycoconjugate Journal.
[39] Y. Kloog,et al. Galectin-1 binds oncogenic H-Ras to mediate Ras membrane anchorage and cell transformation , 2001, Oncogene.
[40] Richard D. Cummings,et al. Galectins: A family of animal β-galactoside-binding lectins , 1994, Cell.
[41] Xiaodong Wang,et al. Galectin-1 induces nuclear translocation of endonuclease G in caspase- and cytochrome c-independent T cell death , 2004, Cell Death and Differentiation.
[42] S. Barondes,et al. Evidence for export of a muscle lectin from cytosol to extracellular matrix and for a novel secretory mechanism , 1990, The Journal of cell biology.
[43] B. Wiedenmann,et al. Human Galectin-2: Novel Inducer of T Cell Apoptosis with Distinct Profile of Caspase Activation1 , 2004, The Journal of Immunology.
[44] A. Raz,et al. Galectin-3 enhances cyclin D1 promoter activity through SP1 and a cAMP-responsive element in human breast epithelial cells , 2002, Oncogene.
[45] Riyao Yang,et al. Expression of galectin-3 modulates T-cell growth and apoptosis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[46] M. Matsuda,et al. Galectin-12, an Adipose-expressed Galectin-like Molecule Possessing Apoptosis-inducing Activity* , 2001, The Journal of Biological Chemistry.
[47] F. T. Liu,et al. Galectins: A new family of regulators of inflammation , 2000 .
[48] Timothy R Billiar,et al. Role of galectin-3 in breast cancer metastasis: involvement of nitric oxide. , 2002, The American journal of pathology.
[49] John L. Wang,et al. Identification of galectin-3 as a factor in pre-mRNA splicing. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[50] C. Bruni,et al. Galectin genes: Regulation of expression , 2004, Glycoconjugate Journal.
[51] Fu-Tong Liu,et al. Suppression of Tumor Growth by Galectin-7 Gene Transfer , 2004, Cancer Research.
[52] H. Pircher,et al. Beta-galactoside-binding protein secreted by activated T cells inhibits antigen-induced proliferation of T cells. , 1998, European journal of immunology.
[53] C. Uyttenhove,et al. Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase , 2003, Nature Medicine.
[54] M. Hirashima,et al. Galectin-8 modulates neutrophil function via interaction with integrin alphaM. , 2003, Glycobiology.
[55] K. Mishima,et al. Expression of galectin‐1 mRNA correlates with the malignant potential of human gliomas and expression of antisense galectin‐1 inhibits the growth of 9 glioma cells , 2000, Journal of neuroscience research.
[56] A. Hoeflich,et al. Tumor galectinology: Insights into the complex network of a family of endogenous lectins , 2003, Glycoconjugate Journal.
[57] Douglas N W Cooper,et al. Galectinomics: finding themes in complexity. , 2002, Biochimica et biophysica acta.
[58] R. Lotan,et al. Differential regulation of constitutive and retinoic acid-induced galectin-1 gene transcription in murine embryonal carcinoma and myoblastic cells. , 2000, Biochimica et biophysica acta.
[59] N. Mitsiades,et al. Fas ligand expression in thyroid carcinomas: a potential mechanism of immune evasion. , 1999, The Journal of clinical endocrinology and metabolism.
[60] Susanne Carlsson,et al. Introduction to galectins , 1997, Glycoconjugate Journal.
[61] C. Colnot,et al. Maintenance of granulocyte numbers during acute peritonitis is defective in galectin‐3‐null mutant mice , 1998, Immunology.
[62] J. Le Pennec,et al. Human galectin-8 isoforms and cancer , 2004, Glycoconjugate Journal.
[63] M. Hirashima,et al. Galectin-8 modulates neutrophil function via interaction with integrin alphaM. , 2003, Glycobiology.
[64] S. Tsuboi,et al. Expression of a Specific Glycosyltransferase Enzyme Regulates T Cell Death Mediated by Galectin-1* , 2000, The Journal of Biological Chemistry.
[65] O. Kalayci,et al. Critical role for galectin-3 in airway inflammation and bronchial hyperresponsiveness in a murine model of asthma. , 2004, The American journal of pathology.
[66] N. Sharon,et al. History of lectins: from hemagglutinins to biological recognition molecules. , 2004, Glycobiology.
[67] Haidong Dong,et al. Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion , 2002, Nature Medicine.
[68] A. D. Amo,et al. Galectin-3 down-regulates IL-5 gene expression on different cell types. , 1998, Journal of immunology.
[69] C. Aring,et al. A CRITICAL REVIEW , 1939, Journal of neurology and psychiatry.
[70] L. Mallucci,et al. Cell cycle arrest and induction of apoptosis by β galactoside binding protein (βGBP) in human mammary cancer cells. A potential new approach to cancer control , 1999 .
[71] M. Teitell,et al. An anti-apoptotic role for galectin-3 in diffuse large B-cell lymphomas. , 2004, The American journal of pathology.
[72] 赤埴 詩朗. Galectin-3 : a novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family , 2000 .
[73] G. Rabinovich,et al. Activated rat macrophages produce a galectin-1-like protein that induces apoptosis of T cells: biochemical and functional characterization. , 1998, Journal of immunology.
[74] J. Hirabayashi,et al. A novel biological activity for galectin-1: inhibition of leukocyte-endothelial cell interactions in experimental inflammation. , 2003, The American journal of pathology.
[75] R. Kiss,et al. Galectin‐1 Modulates Human Glioblastoma Cell Migration into the Brain Through Modifications to the Actin Cytoskeleton and Levels of Expression of Small GTPases , 2002, Journal of neuropathology and experimental neurology.
[76] W. Song,et al. Selective modulation of the interaction of α 7 β 1 integrin with fibronectin and laminin by L-14 lectin during skeletal muscle differentiation , 1996 .
[77] M. Karin,et al. Inhibition of NF-κB in cancer cells converts inflammation- induced tumor growth mediated by TNFα to TRAIL-mediated tumor regression , 2004 .
[78] H. Ahmed,et al. C-type lectins and galectins mediate innate and adaptive immune functions: their roles in the complement activation pathway. , 1999, Developmental and comparative immunology.
[79] Y. Takenaka,et al. Galectin-3, a Novel Binding Partner of β-Catenin , 2004, Cancer Research.
[80] R. Liskamp,et al. Wedgelike Glycodendrimers as Inhibitors of Binding of Mammalian Galectins to Glycoproteins, Lactose Maxiclusters, and Cell Surface Glycoconjugates , 2001, Chembiochem : a European journal of chemical biology.
[81] G. Rabinovich,et al. Molecular mechanisms implicated in galectin-1-induced apoptosis: activation of the AP-1 transcription factor and downregulation of Bcl-2 , 2000, Cell Death and Differentiation.
[82] J. Dennis,et al. Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation , 2001, Nature.
[83] T. Yoshii,et al. Nuclear Export of Phosphorylated Galectin-3 Regulates Its Antiapoptotic Activity in Response to Chemotherapeutic Drugs , 2004, Molecular and Cellular Biology.
[84] R. Cummings,et al. Dimeric Galectin-1 Induces Surface Exposure of Phosphatidylserine and Phagocytic Recognition of Leukocytes without Inducing Apoptosis* , 2003, Journal of Biological Chemistry.
[85] K. Okuno,et al. Role of galectin-3 in adenocarcinoma liver metastasis. , 2001, International journal of oncology.
[86] T. Yoshii,et al. Galectin-3 Phosphorylation Is Required for Its Anti-apoptotic Function and Cell Cycle Arrest* , 2002, The Journal of Biological Chemistry.
[87] Fu-Tong Liu,et al. Functions of galectins in cell adhesion and chemotaxis. , 2003, Methods in enzymology.
[88] Sachiko Sato,et al. Seeing strangers or announcing “danger”: Galectin-3 in two models of innate immunity , 2004, Glycoconjugate Journal.
[89] V. Castronovo,et al. Dual activities of galectin-3 in human prostate cancer: tumor suppression of nuclear galectin-3 vs tumor promotion of cytoplasmic galectin-3 , 2004, Oncogene.
[90] J. Ochieng,et al. Galectin-3 mediates the endocytosis of β-1 integrins by breast carcinoma cells , 2001 .
[91] Y. Takenaka,et al. Galectin-3 and metastasis , 2004, Glycoconjugate Journal.
[92] N. Tinari,et al. Galectin‐3 overexpression protects from apoptosis by improving cell adhesion properties , 2000, International journal of cancer.
[93] S. Snapper,et al. Induced reactivity of intestinal CD4(+) T cells with an epithelial cell lectin, galectin-4, contributes to exacerbation of intestinal inflammation. , 2004, Immunity.
[94] Ariel,et al. Specific inhibition of T‐cell adhesion to extracellular matrix and proinflammatory cytokine secretion by human recombinant galectin‐1 , 1999, Immunology.
[95] J. Ochieng,et al. Galectin‐3 regulates the adhesive interaction between breast carcinoma cells and elastin , 1999, Journal of cellular biochemistry.
[96] R. Schreiber,et al. The immunobiology of cancer immunosurveillance and immunoediting. , 2004, Immunity.
[97] Y. Takenaka,et al. Galectins and urological cancer , 2004, Journal of cellular biochemistry.
[98] H. Gabius,et al. Galectin-3 Precipitates as a Pentamer with Synthetic Multivalent Carbohydrates and Forms Heterogeneous Cross-linked Complexes* , 2004, Journal of Biological Chemistry.
[99] L. A. Lewis,et al. Galectin-1 Induces Partial TCR ζ-Chain Phosphorylation and Antagonizes Processive TCR Signal Transduction1 , 2000, The Journal of Immunology.
[100] I Salmon,et al. Galectin-8 expression decreases in cancer compared with normal and dysplastic human colon tissue and acts significantly on human colon cancer cell migration as a suppressor , 2002, Gut.
[101] D. Gabrilovich,et al. Tumor escape from immune response: mechanisms and targets of activity. , 2003, Current drug targets.
[102] G. Rabinovich,et al. Shedding light on the immunomodulatory properties of galectins: Novel regulators of innate and adaptive immune responses , 2004, Glycoconjugate Journal.
[103] P. Stewart,et al. Restricted receptor segregation into membrane microdomains occurs on human T cells during apoptosis induced by galectin-1. , 1999, Journal of immunology.
[104] R.-Y. Yang,et al. Galectins in cell growth and apoptosis , 2003, Cellular and Molecular Life Sciences CMLS.
[105] G. Glinsky,et al. MDA-MB-435 Human Breast Carcinoma Cell Homo- and Heterotypic Adhesion under Flow Conditions Is Mediated in Part by Thomsen-Friedenreich Antigen-Galectin-3 Interactions* , 2003, The Journal of Biological Chemistry.
[106] Y. Kloog,et al. Galectin-3 Augments K-Ras Activation and Triggers a Ras Signal That Attenuates ERK but Not Phosphoinositide 3-Kinase Activity* , 2004, Journal of Biological Chemistry.
[107] R. Bresalier,et al. Metastasis of human colon cancer is altered by modifying expression of the beta-galactoside-binding protein galectin 3. , 1998, Gastroenterology.
[108] D. Green,et al. Galectin-7 (PIG1) Exhibits Pro-apoptotic Function through JNK Activation and Mitochondrial Cytochrome cRelease* 210 , 2002, The Journal of Biological Chemistry.
[109] A. Sarasin,et al. Galectin-7 overexpression is associated with the apoptotic process in UVB-induced sunburn keratinocytes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[110] E. Meeusen,et al. Galectins in parasite infection and allergic inflammation , 2004, Glycoconjugate Journal.
[111] H. Inohara,et al. Down-regulation of galectin-3 suppresses tumorigenicity of human breast carcinoma cells. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[112] T. Yoshii,et al. Galectin-3 maintains the transformed phenotype of thyroid papillary carcinoma cells. , 2001, International journal of oncology.
[113] T. Feizi. Progress in deciphering the information content of the ‘glycome’ – a crescendo in the closing years of the millennium , 2000, Glycoconjugate Journal.
[114] G. Rabinovich,et al. Induction of allogenic T-cell hyporesponsiveness by galectin-1-mediated apoptotic and non-apoptotic mechanisms , 2002, Cell Death and Differentiation.
[115] D. Pardoll,et al. Does the immune system see tumors as foreign or self? , 2003, Annual review of immunology.
[116] Jian Ni,et al. Cell Cycle Regulation by Galectin-12, a New Member of the Galectin Superfamily* , 2001, The Journal of Biological Chemistry.
[117] Mariano J. Alvarez,et al. Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection; A potential mechanism of tumor-immune privilege. , 2004, Cancer cell.
[118] B. Lewis. A Historical Overview , 1996 .
[119] K. Pienta,et al. Intravascular metastatic cancer cell homotypic aggregation at the sites of primary attachment to the endothelium. , 2003, Cancer research.
[120] A. Berchuck,et al. Galectin-1 Accumulation in the Ovary Carcinoma Peritumoral Stroma Is Induced by Ovary Carcinoma Cells and Affects Both Cancer Cell Proliferation and Adhesion to Laminin-1 and Fibronectin , 2003, Laboratory Investigation.
[121] A. Kumar,et al. Developmental regulation, expression, and apoptotic potential of galectin-9, a beta-galactoside binding lectin. , 1997, The Journal of clinical investigation.
[122] R. Lotan,et al. Differential expression of endogenous galectin-1 and galectin-3 in human prostate cancer cell lines and effects of overexpressing galectin-1 on cell phenotype. , 1999, International journal of oncology.
[123] A. Scaloni,et al. Nuclear localization of Galectin-3 in transformed thyroid cells: a role in transcriptional regulation. , 2003, Biochemical and biophysical research communications.
[124] J. Dennis,et al. Regulation of Cytokine Receptors by Golgi N-Glycan Processing and Endocytosis , 2004, Science.
[125] Toshihiko Oka,et al. Oligosaccharide specificity of galectins: a search by frontal affinity chromatography. , 2002, Biochimica et biophysica acta.
[126] J. L. Wang,et al. Carbohydrate-binding protein 35. Isoelectric points of the polypeptide and a phosphorylated derivative. , 1990, The Journal of biological chemistry.
[127] G. Rabinovich,et al. Evidence of a role for galectin‐1 in acute inflammation , 2000, European journal of immunology.
[128] L. Baum,et al. Clusters, bundles, arrays and lattices: novel mechanisms for lectin-saccharide-mediated cellular interactions. , 2002, Current opinion in structural biology.
[129] Isabelle Camby,et al. Galectins and cancer. , 2002, Biochimica et biophysica acta.
[130] L. Stephens,et al. Effects of galectin‐3 expression on growth and tumorigenicity of the prostate cancer cell line LNCaP , 2002, The Prostate.
[131] B. Geiger,et al. Galectin-8 Functions as a Matricellular Modulator of Cell Adhesion* , 2001, The Journal of Biological Chemistry.
[132] Yoshifumi Yamamoto,et al. Malignant transformation of thyroid follicular cells by galectin-3. , 2003, Cancer letters.
[133] V. Castronovo,et al. Expression of galectins in cancer: A critical review , 2004, Glycoconjugate Journal.
[134] Hua Yu,et al. The STATs of cancer — new molecular targets come of age , 2004, Nature Reviews Cancer.
[135] H Kaltner,et al. Negative Regulation of Neuroblastoma Cell Growth by Carbohydrate-dependent Surface Binding of Galectin-1 and Functional Divergence from Galectin-3* , 2001, The Journal of Biological Chemistry.
[136] W. Fung-Leung,et al. Targeted disruption of the galectin-3 gene results in attenuated peritoneal inflammatory responses. , 2000, The American journal of pathology.
[137] G. Rabinovich,et al. Galectin-1 suppresses experimental colitis in mice. , 2003, Gastroenterology.
[138] S. Barondes,et al. L-29, a soluble lactose-binding lectin, is phosphorylated on serine 6 and serine 12 in vivo and by casein kinase I. , 1993, The Journal of biological chemistry.
[139] M. Territo,et al. Amelioration of graft versus host disease by galectin-1. , 2003, Clinical immunology.
[140] L. O’Driscoll,et al. Galectin-3 expression alters adhesion, motility and invasion in a lung cell line (DLKP), in vitro. , 2002, Anticancer research.
[141] H. Gabius. Animal lectins. , 1997, European journal of biochemistry.
[142] R. Finley,et al. Galectin-3 Translocates to the Perinuclear Membranes and Inhibits Cytochrome c Release from the Mitochondria , 2002, The Journal of Biological Chemistry.
[143] R. Kiss,et al. Upregulation of galectins‐1 and ‐3 in human colon cancer and their role in regulating cell migration , 2003, International journal of cancer.
[144] F. Balkwill. Cancer and the chemokine network , 2004, Nature Reviews Cancer.
[145] A. Heck,et al. Homodimeric galectin-7 (p53-induced gene 1) is a negative growth regulator for human neuroblastoma cells , 2003, Oncogene.
[146] G. Rabinovich,et al. Galectin-3 Mediates IL-4-Induced Survival and Differentiation of B Cells: Functional Cross-Talk and Implications during Trypanosoma cruzi Infection 1 , 2004, The Journal of Immunology.
[147] L. Baum,et al. Apoptosis of T cells mediated by galectin-1 , 1995, Nature.
[148] K. Pienta,et al. Galectin-3 induces endothelial cell morphogenesis and angiogenesis. , 2000, The American journal of pathology.
[149] H. Erdjument-Bromage,et al. Induction of Terminal Differentiation in Epithelial Cells Requires Polymerization of Hensin by Galectin 3 , 2000, The Journal of cell biology.
[150] A. Raz,et al. Cell cycle arrest and inhibition of anoikis by galectin-3 in human breast epithelial cells. , 1999, Cancer research.